Qiagen NV | Betriebsaufwand



Operating Expenses Veränderung Datum
Alaunos Therapeutics USD 1.15M 20K 2024-09
argenx SE USD 635.37M 62.66M 2024-12
Avita Medical AUD 28.36M 2.44M 2024-12
Dianthus Therapeutics USD 33.24M 1.17M 2024-12
Ionis Pharmaceuticals USD 337.4M 54.93M 2024-12
IQVIA Holdings USD 3.33B 14M 2024-12
Moderna USD 2.21B 280M 2024-12
Organon & Co USD 1.46B 88M 2024-12
Qiagen NV USD 377.04M 4.6M 2024-12
Revvity USD 610.62M 24.72M 2024-12
Tectonic Therapeutic USD 13.99M 5.65M 2024-12
Viatris USD 3.55B 84.2M 2024-12
Xeris Pharmaceuticals USD 58.42M 8.74M 2024-12



Qiagen NV Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.